These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7528313)

  • 1. Use of thiacetazone.
    Wilkinson D; Moore D
    Lancet; 1995 Jan; 345(8941):63. PubMed ID: 7528313
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of thiacetazone.
    Foster S; Kelly P
    Lancet; 1995 Jan; 345(8941):62-3. PubMed ID: 7528311
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.
    Hawken M; Nunn P; Gathua S; Brindle R; Godfrey-Faussett P; Githui W; Odhiambo J; Batchelor B; Gilks C; Morris J
    Lancet; 1993 Aug; 342(8867):332-7. PubMed ID: 7687729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiacetazone: time to call a halt? Considerations on the use of thiacetazone in African populations with a high prevalence of human immunodeficiency virus infection.
    Elliott AM; Foster SD
    Tuber Lung Dis; 1996 Feb; 77(1):27-9. PubMed ID: 8733410
    [No Abstract]   [Full Text] [Related]  

  • 6. Tuberculosis in people with HIV.
    Bellamy R
    Clin Evid; 2005 Dec; (14):858-68. PubMed ID: 16620440
    [No Abstract]   [Full Text] [Related]  

  • 7. Further consequences of thioacetazone-induced cutaneous reactions.
    Lawn SD; Griffin GE
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):92-3. PubMed ID: 10654652
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya.
    van Gorkom J; Kibuga DK
    Tuber Lung Dis; 1996 Feb; 77(1):30-6. PubMed ID: 8733411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebuttal: time to call a halt to emotions in the assessment of thioacetazone.
    Rieder HL; Enarson DA
    Tuber Lung Dis; 1996 Apr; 77(2):109-11. PubMed ID: 8762843
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent developments in the treatment of tuberculosis].
    Press P
    Schweiz Med Wochenschr; 1972 Feb; 102(8):260-5. PubMed ID: 4110824
    [No Abstract]   [Full Text] [Related]  

  • 12. A trial involving HIV-tuberculosis in India: the minute particulars.
    Vernon A
    Am J Respir Crit Care Med; 2010 Apr; 181(7):652-4. PubMed ID: 20335382
    [No Abstract]   [Full Text] [Related]  

  • 13. Wrong drug used for tuberculosis.
    Kelly PM
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):385. PubMed ID: 9432398
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis: guidelines changed for latent TB treatment.
    AIDS Treat News; 2001 Sep; (371):3. PubMed ID: 11668976
    [No Abstract]   [Full Text] [Related]  

  • 15. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Jun; 75(6):358-63. PubMed ID: 9803621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous hypersensitivity reactions to thiacetazone, HIV infection and thiacetazone concentrations in plasma.
    Watkins WM; Mungai M; Muhia DK; Mberu EK; Gathua S; Winstanley PA; Gilks CF; Nunn P
    Br J Clin Pharmacol; 1996 Feb; 41(2):160-2. PubMed ID: 8838444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis].
    Bonnaud F; Zigani A
    Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost savings from alternative treatments for tuberculosis.
    Barnum HN
    Soc Sci Med; 1986; 23(9):847-50. PubMed ID: 2432668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A young man with an expanding neck mass.
    Nguyen C
    CMAJ; 2004 Jan; 170(2):193. PubMed ID: 14734432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.